Cardiorenal Syndrome: Diagnosis and Treatment
In the diagnosis of cardiorenal syndrome (CRS), the biological markers are widely used, they can be applied to identify the pathophysiological stages of CRS, to assess the amount of risk, prognosis and outcome, as well as to monitor the effectiveness of treatment. CRS therapy includes diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, nitrates and cardiac glycosides. One of the most effective methods of CRS treatment is the use of renal replacement therapy..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Počki - 6(2017), 1, Seite 2-14 |
| Sprache: |
Englisch ; Ukrainisch |
|---|
| Beteiligte Personen: |
O.O. Melnyk [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| doi: |
10.22141/2307-1257.6.1.2017.93777 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ013863673 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ013863673 | ||
| 003 | DE-627 | ||
| 005 | 20230310061533.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.22141/2307-1257.6.1.2017.93777 |2 doi | |
| 035 | |a (DE-627)DOAJ013863673 | ||
| 035 | |a (DE-599)DOAJ15ffc564f8dc4707925d681975e0ac07 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a ukr | ||
| 050 | 0 | |a RC870-923 | |
| 100 | 0 | |a O.O. Melnyk |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiorenal Syndrome: Diagnosis and Treatment |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a In the diagnosis of cardiorenal syndrome (CRS), the biological markers are widely used, they can be applied to identify the pathophysiological stages of CRS, to assess the amount of risk, prognosis and outcome, as well as to monitor the effectiveness of treatment. CRS therapy includes diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, nitrates and cardiac glycosides. One of the most effective methods of CRS treatment is the use of renal replacement therapy. | ||
| 650 | 4 | |a cardiorenal syndrome | |
| 650 | 4 | |a biomarkers of cardiorenal syndrome (cardiospecific, cardiorenal, glomerular, proximal, distal) | |
| 650 | 4 | |a treatment of cardiorenal syndrome (diuretics, vasodilators, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonist | |
| 653 | 0 | |a Diseases of the genitourinary system. Urology | |
| 773 | 0 | 8 | |i In |t Počki |d Zaslavsky O.Yu., 2017 |g 6(2017), 1, Seite 2-14 |w (DE-627)DOAJ000141941 |x 23071265 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2017 |g number:1 |g pages:2-14 |
| 856 | 4 | 0 | |u https://doi.org/10.22141/2307-1257.6.1.2017.93777 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/15ffc564f8dc4707925d681975e0ac07 |z kostenfrei |
| 856 | 4 | 0 | |u http://kidneys.zaslavsky.com.ua/article/view/93777 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2307-1257 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2307-1265 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2017 |e 1 |h 2-14 | ||